Japan First To Approve Omarigliptin, Lusutrombopag
This article was originally published in PharmAsia News
Executive Summary
The latest batch of product approvals in Japan includes the first regulatory clearances worldwide for new molecules from Merck and Shionogi, in a further sign that the country's "drug lag" is a thing of the past.